Wealthfront Advisers’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $22.4M | Buy |
263,378
+22,156
| +9% | +$1.97M | 0.05% | 125 |
|
|
2025
Q4 | $19.1M | Buy |
241,222
+33,805
| +16% | +$2.65M | 0.04% | 140 |
|
|
2025
Q3 | $16.6M | Buy |
207,417
+48,960
| +31% | +$4.18M | 0.04% | 148 |
|
|
2025
Q2 | $14.4M | Buy |
158,457
+35,219
| +29% | +$3.22M | 0.04% | 157 |
|
|
2025
Q1 | $11.5M | Buy |
123,238
+7,705
| +7% | +$690K | 0.03% | 177 |
|
|
2024
Q4 | $10.5M | Buy |
115,533
+15,870
| +16% | +$1.51M | 0.03% | 176 |
|
|
2024
Q3 | $10.3M | Buy |
99,663
+1,921
| +2% | +$196K | 0.03% | 158 |
|
|
2024
Q2 | $9.48M | Buy |
97,742
+4,625
| +5% | +$427K | 0.03% | 160 |
|
|
2024
Q1 | $8.39M | Buy |
93,117
+3,001
| +3% | +$254K | 0.03% | 168 |
|
|
2023
Q4 | $7.18M | Buy |
90,116
+18,374
| +26% | +$1.38M | 0.03% | 169 |
|
|
2023
Q3 | $5.1M | Sell |
71,742
-122,953
| -63% | -$9.19M | 0.02% | 205 |
|
|
2023
Q2 | $15M | Buy |
194,695
+47,860
| +33% | +$3.7M | 0.06% | 82 |
|
|
2023
Q1 | $11M | Sell |
146,835
-7,277
| -5% | -$541K | 0.05% | 107 |
|
|
2022
Q4 | $12.1M | Sell |
154,112
-17,341
| -10% | -$1.3M | 0.06% | 91 |
|
|
2022
Q3 | $12M | Buy |
171,453
+12,239
| +8% | +$960K | 0.06% | 78 |
|
|
2022
Q2 | $12.8M | Buy |
159,214
+75,169
| +89% | +$5.88M | 0.06% | 74 |
|
|
2022
Q1 | $6.37M | Sell |
84,045
-5,919
| -7% | -$469K | 0.03% | 169 |
|
|
2021
Q4 | $7.68M | Buy |
89,964
+19,326
| +27% | +$1.51M | 0.03% | 131 |
|
|
2021
Q3 | $5.34M | Buy |
70,638
+3,188
| +5% | +$253K | 0.02% | 152 |
|
|
2021
Q2 | $5.49M | Buy |
67,450
+11,849
| +21% | +$969K | 0.03% | 127 |
|
|
2021
Q1 | $4.38M | Buy |
55,601
+7,917
| +17% | +$621K | 0.02% | 130 |
|
|
2020
Q4 | $4.08M | Buy |
47,684
+15,198
| +47% | +$1.26M | 0.02% | 113 |
|
|
2020
Q3 | $2.51M | Buy |
32,486
+2,991
| +10% | +$228K | 0.02% | 143 |
|
|
2020
Q2 | $2.16M | Buy |
29,495
+1,415
| +5% | +$101K | 0.02% | 153 |
|
|
2020
Q1 | $1.86M | Sell |
28,080
-5,507
| -16% | -$388K | 0.02% | 155 |
|
|
2019
Q4 | $2.31M | Sell |
33,587
-1,253
| -4% | -$85.4K | 0.02% | 153 |
|
|
2019
Q3 | $2.56M | Sell |
34,840
-999
| -3% | -$72.5K | 0.02% | 131 |
|
|
2019
Q2 | $2.57M | Buy |
35,839
+1,588
| +5% | +$113K | 0.02% | 130 |
|
|
2019
Q1 | $2.35M | Buy |
34,251
+1,006
| +3% | +$65K | 0.02% | 126 |
|
|
2018
Q4 | $1.98M | Buy |
+33,245
| New | +$2.08M | 0.02% | 127 |
|
Other funds holding CL
VCM
DAM
VPM
Wealthfront Advisers's CL Position: Q1 2026 in Review
Wealthfront Advisers increased its Colgate-Palmolive (CL) stake by 9.2% in Q1 2026, buying an estimated $1.97M and bringing the position to 263,378 shares worth $22.4M. The position accounts for 0.05% of the portfolio, ranked #125.
Wealthfront Advisers first reported a position in CL in Q4 2018 and has held it in 30 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Wealthfront Advisers held 263,378 shares of Colgate-Palmolive worth $22.4M as of Q1 2026.
- Wealthfront Advisers bought 22,156 Colgate-Palmolive shares in Q1 2026, an estimated $1.97M.
- Colgate-Palmolive made up 0.05% of Wealthfront Advisers's portfolio in Q1 2026, its #125 holding.
- Wealthfront Advisers first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 30 quarters since.
- 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Wealthfront Advisers's 13F filing for Q1 2026, filed 5 May 2026.